KEGEL
发表于 2025-3-28 17:45:15
N. Sundararajan,P. Saratchandran,Yan Licers. It is a prevalent disease in older patients, but the incidence is rising in younger ones. The systemic therapy generally most used in metastatic CCR includes the basis of chemotherapy paired with a biological treatment. Usually, chemotherapy is composed of fluoropyrimidines combined with oxali
anachronistic
发表于 2025-3-28 19:38:41
N. Sundararajan,P. Saratchandran,Yan Liy of LC (about 80–85%) is non-small cell (NSCLC), whose 5-year survival is about 50%, falling to 1% with the progress of the disease. The majority (80%) of diagnoses are late and with locally advanced disease (22%) or metastatic disease (57%), requiring chemotherapy and/or radiotherapy. The NSCLC is
平项山
发表于 2025-3-29 02:30:06
http://reply.papertrans.cn/17/1644/164316/164316_43.png
歪曲道理
发表于 2025-3-29 03:21:45
http://reply.papertrans.cn/17/1644/164316/164316_44.png
非实体
发表于 2025-3-29 07:41:56
http://reply.papertrans.cn/17/1644/164316/164316_45.png
SOB
发表于 2025-3-29 12:46:40
0.5-V MTCMOS/SOI Digital Circuits,ty is to control cancer, since it harbors heterogeneous characteristics and the processes, which are coordinated by a precise and well-organized machinery. The heterogeneity may be represented at many different levels: interpatient, intrapatient, and intratumoral. Additionally, the heterogeneity com
acrophobia
发表于 2025-3-29 15:32:46
http://reply.papertrans.cn/17/1644/164316/164316_47.png
PANEL
发表于 2025-3-29 20:34:25
http://reply.papertrans.cn/17/1644/164316/164316_48.png
阴郁
发表于 2025-3-30 01:36:48
http://reply.papertrans.cn/17/1644/164316/164316_49.png
NAVEN
发表于 2025-3-30 06:56:36
http://reply.papertrans.cn/17/1644/164316/164316_50.png